Mast cell tumor surgery: Difference between revisions

	Mast cell tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mast Cell Tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Diagnostic criteria
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography or Ultrasound
CT Scan
MRI
Biopsy
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mast cell tumor surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mast cell tumor surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mast cell tumor surgery
CDC on Mast cell tumor surgery
Mast cell tumor surgery in the news
Blogs on Mast cell tumor surgery
Directions to Hospitals Treating Mast cell tumor
Risk calculators and risk factors for Mast cell tumor surgery

Revision as of 15:18, 8 March 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Surgical intervention is not recommended for the management of mast cell tumor.

Surgical intervention is not recommended for the management of mast cell tumor.

@@ Line 3: / Line 3: @@
 {{CMG}}
 ==Overview==
+Surgical intervention is not recommended for the management of mast cell tumor.
 ==Surgery==
-In the surgical setting it is recommended to avoid beta-blockers as they interfere with endogenous epinephrine and may precipitate anaphylaxis.  It is also recommended to avoid alpha-blockers as well as anti-cholinergics. Care must be taken in the perioperative management of the patient with systemic mastocytosis.  Certain anesthetic and analgesic medications can serve as a trigger of an acute exacerbation of mastocytosis <ref name="pmid19213401">{{cite journal |author=Chaar CI, Bell RL, Duffy TP, Duffy AJ |title=Guidelines for safe surgery in patients with systemic mastocytosis |journal=[[The American Surgeon]] |volume=75 |issue=1 |pages=74–80 |year=2009 |month=January |pmid=19213401 |doi= |url=http://openurl.ingenta.com/content/nlm?genre=article&issn=0003-1348&volume=75&issue=1&spage=74&aulast=Chaar |issn= |accessdate=2012-08-18}}</ref>. Peri-operative administration of [[antihistamines]] such as [[benadryl]] and steroids such as [[Solumedrol]] may be necessary.
+Surgical intervention is not recommended for the management of mast cell tumor.
 ==References==
@@ Line 12: / Line 14: @@
 {{WS}}
-[[Category:Needs content]]
 [[Category:Disease]]
 [[Category:Types of cancer]]
 [[Category:Pathology]]